CUSIP 22663K107COMCRNXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
240 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Fmr LLC | 14.29M | $665.38M | +106.3K | Added |
| 2 | Vanguard Group Inc | 9.14M | $425.26M | −34.6K | Reduced |
| 3 | Wellington Management Group LLP | 8.04M | $374.16M | −344.1K | Reduced |
| 4 | Blackrock, Inc. | 7.99M | $371.87M |
| +402.0K |
| Added |
| 5 | Farallon Capital Management LLC | 6.93M | $322.74M | +1.16M | Added |
| 6 | Driehaus Capital Management LLC | 6.39M | $297.35M | −93.9K | Reduced |
| 7 | Janus Henderson Group PLC | 4.44M | $206.60M | +581.9K | Added |
| 8 | Ecor1 Capital, LLC | 4.29M | $199.61M | 0 | Held |
| 9 | Point72 Asset Management, L.P. | 2.34M | $108.79M | +333.7K | Added |
| 10 | Geode Capital Management, LLC | 2.24M | $104.41M | −36.2K | Reduced |
See every fund holding Crinetics Pharmaceuticals In, with full quarter-over-quarter share changes.
Unlock all holders